Metastatic Breast Cancer Collaborative Research Summit

Komen Scholar, Dr. Yibin Kang, Warner-Lambert/Parke-Davis Professor at Princeton University

MBC Research: Where We Are and Where We Are Going

___________________________________________________________

• Hear scientific presentations from researchers from our founding institutions, Duke Cancer Institute and the UNC Lineberger Comprehensive Cancer Center.

• Learn more about Komen’s new MBC Collaborative Research Grants and upcoming funding opportunities.

• Participate in roundtable discussions to learn about the current gaps in MBC research and discuss actionable solutions to drive further discoveries in the field that will ultimately save lives.

• Meet potential collaborators to expand and develop new ideas for approaches to MBC across other local institutions.

• Hear valuable perspectives from MBC patient advocates.

The Komen Metastatic Breast Cancer Collaborative Research Initiative, launched in North Carolina in 2020, was founded to catalyze research collaborations between our founding research institutions: Duke University and the University of North Carolina (UNC) Chapel Hill. Our singular goal is to fund groundbreaking metastatic breast cancer (MBC) research to improve outcomes for those living with the disease and one day find the cures to end it. We hope to expand this fund and invite additional North Carolina based research institutions to join us in our mission.

Host or Publisher Susan G. Komen